Kodiak Sciences says Zenkuda meets primary endpoint in Phase 3 wet AMD trial
The company said both Zenkuda and tabirafusp-ted matched aflibercept on vision outcomes at one year in the DAYBREAK study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.